Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Depreciation & Amortization - Total (2018 - 2020)

Avai Bio's Depreciation & Amortization - Total history spans 3 years, with the latest figure at $14378.0 for Q4 2020.

  • For Q4 2020, Depreciation & Amortization - Total rose 75.56% year-over-year to $14378.0; the TTM value through Dec 2022 reached $14378.0, changed N/A, while the annual FY2024 figure was $1500.0, N/A changed from the prior year.
  • Depreciation & Amortization - Total for Q4 2020 was $14378.0 at Avai Bio, up from $14256.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $16748.0 in Q1 2020 and bottomed at $2165.0 in Q4 2018.
  • The 3-year median for Depreciation & Amortization - Total is $9837.0 (2019), against an average of $9052.3.
  • The largest YoY upside for Depreciation & Amortization - Total was 673.58% in 2020 against a maximum downside of 44.92% in 2020.
  • A 3-year view of Depreciation & Amortization - Total shows it stood at $2165.0 in 2018, then surged by 278.29% to $8190.0 in 2019, then surged by 75.56% to $14378.0 in 2020.
  • Per Business Quant, the three most recent readings for AVAI's Depreciation & Amortization - Total are $14378.0 (Q4 2020), $14256.0 (Q3 2020), and $11567.0 (Q2 2020).